deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT03568643

Azithromycin for Uncomplicated Severe Acute Malnutrition in Burkina Faso (Pilot) (SAM)

Azithromycin as Adjunctive Therapy for Uncomplicated Severe Acute Malnutrition:

Sponsor: Centre de Recherche en Sante de Nouna, Burkina Faso

Conditions Uncomplicated Severe Acute Malnutrition
Interventions Amoxicillin Azithromycin
Updated 18 times since 2018 Last updated: Aug 10, 2022 Started: Jun 3, 2020 Primary completion: Dec 25, 2020 Completion: Dec 25, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03568643, this PHASE3 trial focuses on Uncomplicated Severe Acute Malnutrition and remains completed. Sponsored by Centre de Recherche en Sante de Nouna, Burkina Faso, it has been updated 18 times since 2020, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Dec 2018 · 3 months · monthly snapshot~Dec 2018 – ~Aug 2019 · 8 months · monthly snapshot~Aug 2019 – ~Oct 2019 · 2 months · monthly snapshot~Oct 2019 – ~Jun 2020 · 8 months · monthly snapshot~Jun 2020 – ~Jul 2020 · 30 days · monthly snapshot~Jul 2020 – ~Aug 2020 · 31 days · monthly snapshot~Aug 2020 – ~Dec 2020 · 4 months · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Sep 2021 · 6 months · monthly snapshot~Sep 2021 – ~Sep 2022 · 12 months · monthly snapshot~Sep 2022 – ~Dec 2022 · 3 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

18 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE3

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE3

  5. Sep 2022 — Dec 2022 [monthly]

    Completed PHASE3

▶ Show 13 earlier versions

  1. Sep 2021 — Sep 2022 [monthly]

    Completed PHASE3

    Phase: PHASE4 → PHASE3

  2. Mar 2021 — Sep 2021 [monthly]

    Completed PHASE4

    Status: Recruiting → Completed

  3. Jan 2021 — Mar 2021 [monthly]

    Recruiting PHASE4

  4. Dec 2020 — Jan 2021 [monthly]

    Recruiting PHASE4

  5. Aug 2020 — Dec 2020 [monthly]

    Recruiting PHASE4

  6. Jul 2020 — Aug 2020 [monthly]

    Recruiting PHASE4

    Status: Not Yet Recruiting → Recruiting

  7. Jun 2020 — Jul 2020 [monthly]

    Not Yet Recruiting PHASE4

  8. Oct 2019 — Jun 2020 [monthly]

    Not Yet Recruiting PHASE4

  9. Aug 2019 — Oct 2019 [monthly]

    Not Yet Recruiting PHASE4

  10. Dec 2018 — Aug 2019 [monthly]

    Not Yet Recruiting PHASE4

  11. Sep 2018 — Dec 2018 [monthly]

    Not Yet Recruiting PHASE4

  12. Aug 2018 — Sep 2018 [monthly]

    Not Yet Recruiting PHASE4

  13. Jul 2018 — Aug 2018 [monthly]

    Not Yet Recruiting PHASE4

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centre de Recherche en Sante de Nouna, Burkina Faso
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
  • University of California, San Francisco
Data source: University of California, San Francisco

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations